Helen C. Adams Immix Biopharma, Inc. (IMMX) insider trading activity
Helen C. Adams is Director of Immix Biopharma, Inc.. Currently has a direct ownership of 174,754 shares of IMMX, which is worth approximately $277,858. The most recent transaction as insider was on May 20, 2024, when has been sold 74,241 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
175K
0%
3M change
1244.26%
12M change
Total Value Held
$277,858
Helen C. Adams Transaction History
Also insider at
HCA
Helen C. Adams
Director
Los Angeles, CA